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Using donated human embryos for scientific research raises ethical questions about the donation process.
We describe a two-stage consent process designed to help couples make informed decisions about embryo
disposition. This consent methodology minimizes conflict of interest, respects patient choice, and provides
a much-needed resource to patients and the research community.While human embryonic stem cell re-
search has made great strides over the
last decade, our lack of understanding of
early human development cannot be
overestimated. Unraveling the properties
of the human embryo has broad conse-
quences for both regenerative medicine
and assisted reproductive technologies
(ART). We know little about the optimal
culture conditions for embryos or the
inherent instabilities and therapeutic risks
of the embryonic stem cell lines derived
from them (Adewumi et al., 2007; Lerou
et al., 2008). Moreover, after 30 years of
ART practice, fertility clinics are still
unable to distinguish embryos with the
potential to develop from those that will
not, resulting in the transfer of multiple
embryos. Often, fertility procedures result
in multiple births and adverse sequelae,
such as the need for fetal reduction and
high miscarriage rates (Racowsky et al.,
2000). Recently, we reported a successful
approach for early diagnosis of embryo
potential in ART. We demonstrated that
human embryo development correlated
with time-lapse image analysis and gene
expression profiling. Developmental
success to the blastocyst stage could be
predicted with > 93% sensitivity and
specificity (Wong et al., 2010).
These results would not have been
possible without donated embryos. There
are little available data on the number of
cryopreserved embryos available for
research. A widely cited 2003 survey of
340 U.S. clinics estimated as many as
400,000 embryos stored in freezers, of
which only 11,000 had been designated
for research (Hoffman et al., 2003). Every360 Cell Stem Cell 8, April 8, 2011 ª2011 Elsyear, thousands of embryos are not trans-
ferred to patients after fertility treatments
and are discarded, as embryo quality is
too poor for use in ART (Knopman et al.,
2010). Over time, most couples choose
to discard their embryos if they no longer
need them.
Using embryos for research raises
important ethical questions about the
donation process. Informed decisions
can be hampered by a lack of clear
processes to facilitate decision-making.
Donation processes should minimize
conflicts of interest and undue influence.
Descriptions of the type of research and
its potential impact on a donor’s privacy
and future health should be communi-
cated in clear and unambiguous
language. Importantly, patients should
be able to make voluntary and educated
decisions about donation through the
core properties of informed consent,
a process by which patients learn key
facts about what will be done with their
embryos. Informedconsent shouldenable
a knowledgeable and deliberate choice
(Cohen, 2009; Lyerly and Faden, 2007).
In order to address these issues, we
developed a multi-stage, interactive con-
senting process for research donation,
which gives couples time to deliberate and
consult with others before making a deci-
sion and time to review the decision once
they have made it. Our methodology was
deployed at Stanford and at 39 ASRM-
certified fertility clinics and three storage
facilities across 20 states (see Table S1
available online). Donated embryos were
deposited in a biobank at Stanford Univer-
sity’s Institute for Stem Cell Biology andevier Inc.Regenerative Medicine. These cryopre-
served embryos would be used to enable
future projects, including human embryo
culture, molecular genetic analysis, and
pluripotent stem cell research. This report
describes data collected from January
2008 through September 2010.
Each year, couples receive an embryo
storage bill from their IVF clinic or storage
facility, at which time they must make a
decision to pay storage fees to keep their
embryos for future reproductive use or to
discard them. In some cases, disposition
options include donation of embryos to
research or to another couple for their
reproductive use. With no current maxi-
mum storage limit in the United States,
couples may revisit this decision each
year.
Our process involved two steps. First,
participating clinics sent embryo disposi-
tion options to couples with the monthly
storage bills. If the couple chose the
research donation option, the clinic then
sent them the Stanford biobank informed
consent packet or instructed them to call
the biobank to receive a consent packet.
Each packet contains detailed donation
instructions, a research consent docu-
ment, a health questionnaire, and contact
information for biobank coordinators. This
method allowed individuals and their
families to deliberate their donation pref-
erences at home on their own time. Phone
consents comprised the second step.
Once a putative decision to donate had
been made, couples were instructed to
call biobank coordinators, pose ques-
tions, ask for clarifications, and, finally,
confirm their donation preferences.
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to donate to either one or both of two
classes of research:
d Class 1 (human development) re-
search uses embryos to learn more
about early human development,
embryo quality, and improving IVF
clinical outcomes, includingprojects
such as embryo imaging studies or
culture media comparisons.
d Class 2 (stem cell) research uses
embryos for embryonic stem cell
research by making cell lines, which
might be used to develop therapies
to treat injured tissue, diseases, and
disorders.
The consent forms also described what
was to be done with the embryos.
Embryos used for human development
research would not be cultured longer
than 12 days and would not result in the
production of a stem cell line. Embryos
used for stem cell research could be
used to derive stem cell lines, and thus
the donor DNA could potentially be prop-
agated indefinitely. Patients who used
donor gametes received a ‘‘donor only’’
packet. Because original signatures are
required from gamete donors in order to
permit line derivation, these individuals
could donate only to human development
research. The consent forms also asked
both partners to choose whether they
wanted to be recontacted by investiga-
tors if research revealed clinically relevant
genetic information. If couples donated to
stem cell research, they were asked to
choose whether they could be contacted
and asked for additional health informa-
tion if the stem cell lines offered a potential
medical benefit.
To better explain the consequences of
the receipt of genetic information, the
consent form described three types of
data that might result from future re-
search. Consent materials stated that
research might reveal that donors may
carry a gene for a particular disease (1)
that can be treated, (2) for which there is
no current treatment, and (3) of which
donors might consider informing relatives
that they, too, might carry the gene in
question.
In addition, consent materials stipu-
lated that embryos could be stored indef-
initely in a tissue bank and would be
manipulated and destroyed during theresearch process, lines containing the
donors’ DNA could be kept and grown
formany years andused for future studies,
and embryos would never be used to
make a baby. Donors had the option to
withdraw their consent at any time prior
to the embryos being used. There was
no age limit for donated embryos, and all
stages of embryos were accepted.
Donors were told they would not be paid
for their donation and would not benefit
from future commercial applications of
the research. Biobank coordinators
administering the consents were not
members of the fertility clinics or the basic
research teams. The complete informed
consent document can be found in the
Supplemental Information online.
At their own convenience and prior to
completing the written consent, donors
were instructed to call the biobank to
complete the phone consent. During the
call, staff followed a predetermined script
to confirm patients’ understanding of
the differences between categories of re-
search, what it means to be recontacted
by researchers, and that embryos in a bio-
bank could be used at any time. Donors
were encouraged to ask questions about
the potential research projects. Once a
set of donors had provided their consent,
coordinators would work directly with
the couple’s IVF clinic to transfer the
embryos. Upon arrival at the biobank,
the embryos were assigned a random
number to deidentify the patients’ health
information and then put into storage.
Under this consenting process, 403
couples donated 1356 embryos for re-
search. The average age of female donors
was 39 years (date of birth to freeze date),
and the average length of embryo storage
was 3.5 years (date of received consent to
freeze date). Twenty-two percent of
patients who provided consent used
donor gametes. Out of respect for some
individuals’ anonymity and because it is
not practical to track down donors much
later during a research study, original
gamete donors were not contacted with
requests for their consent to donate the
resulting embryos.
Our data reveal that donors using their
own gametes did not appear to discrimi-
nate between human development and
stem cell research. Of this group, 32%
donated only to human development
research, 30% donated only to stem cell
research, and 38% chose both types ofCell Stem Cresearch.Wefindnodifference indonation
preferences between those individuals
who provided consent through interac-
tions with Stanford University and those
who were originally contacted through
outside clinics (Pearson’s chi-square
test = 0.43; p = 0.86). In terms of recontact
choices, similar percentages of donors
consented to health (63%) and genetic
recontact (67%) options. This process
minimizes conflicts of interest: Decisions
about embryo disposition are made at
home and there is no direct contact with
biobank personnel unless the donors
decide to proceed with donation. In addi-
tion, participating clinics outside Stanford
are not involved with the research con-
ducted using the donated embryos.
The second-stage phone consent
process affirmed that most couples had
settled on a decision to donate to research
prior to contacting the biobank. Couples
asked specific questions about the
research methods, such as how their
embryos would be manipulated and how
long they would be grown. Some asked
what class of research was most in need
ofembryos.Even though theconsentmate-
rials explicitly stated that embryos would
never be used to make a baby, the primary
concern expressed by donors was that
their embryos would somehow be donated
toanothercouple for their reproductiveuse.
We confirmed with callers that embryos
donated to the biobank would never be
used for reproductive purposes.
In sum, clear explanations of the types of
research and potential health and genetic
outcomes help donors make voluntary and
informed decisions. A two-stage consent
process with no time pressures provides
further flexibility in terms of a deliberative
choice and opportunities to ask important
questionsaboutwhatcanbeanemotionally
charged decision. These features result in
donations that respect patient choice while
providing a much-needed resource to the
research community.SUPPLEMENTAL INFORMATION
Supplemental Information includes sample
informed consent and one table and can be found
with this article online at doi:10.1016/j.stem.2011.
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